» Articles » PMID: 26401978

Decreased Gluconeogenesis in the Absence of Cystathionine Gamma-Lyase and the Underlying Mechanisms

Overview
Specialty Endocrinology
Date 2015 Sep 25
PMID 26401978
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To investigate the regulation of hepatic glucose production by cystathionine γ-lyase (CSE)-generated hydrogen sulfide (H2S) in hepatic glucose production under physiological conditions.

Results: We found that CSE knockout (KO) mice had a reduced rate of gluconeogenesis, which was reversed by administration of NaHS (an H2S donor) (i.p.). Interestingly, isolated CSE KO hepatocytes exhibited a reduced glycemic response to chemical-induced activation of the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) and glucocorticoid pathways compared with wild-type (WT) hepatocytes. Treatment with the inhibitors for PKA (KT5720) or glucocorticoid receptor (GR) (RU-486) significantly reduced H2S-stimulated glucose production from both WT and CSE KO mouse hepatocytes. NaHS treatment upregulated the protein levels of key gluconeogenic transcription factors, such as peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) and CCAAT-enhancer-binding protein-β (C/EBP-β). Moreover, exogenous H2S augmented the S-sulfhydration of the rate-limiting gluconeogenic enzymes and PGC-1α and increased their activities, which were lower in untreated CSE KO hepatocytes. Finally, knockdown of PGC-1α, but not C/EBP-β, significantly decreased NaHS-induced glucose production from the primary hepatocytes.

Innovation: This study demonstrates the stimulatory effect of endogenous H2S on liver glucose production and reveals three underlying mechanisms; that is, H2S upregulates the expression levels of PGC-1α and phosphoenolpyruvate carboxykinase via the GR pathway; H2S upregulates the expression level of PGC-1α through the activation of the cAMP/PKA pathway as well as PGC-1α activity via S-sulfhydration; and H2S upregulates the expression and the activities (by S-sulfhydration) of glucose-6-phosphatase and fructose-1,6-bisphosphatase.

Conclusion: This study may offer clues for the homeostatic regulation of glucose metabolism under physiological conditions and its dysregulation in metabolic syndrome.

Citing Articles

Hydrogen sulfide-induced post-translational modification as a potential drug target.

Chen H, Qian L, Li K, Qin Y, Zhou J, Ji X Genes Dis. 2023; 10(5):1870-1882.

PMID: 37492730 PMC: 10363594. DOI: 10.1016/j.gendis.2022.03.022.


Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review.

Li Y, Yang S, Jin X, Li D, Lu J, Wang X Front Pharmacol. 2023; 14:1082817.

PMID: 36733506 PMC: 9886688. DOI: 10.3389/fphar.2023.1082817.


Function of gaseous hydrogen sulfide in liver fibrosis.

Lee J, Im S BMB Rep. 2022; 55(10):481-487.

PMID: 36195563 PMC: 9623240.


β Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide.

Mitidieri E, Pecoraro A, Esposito E, Brancaleone V, Turnaturi C, Napolitano L Antioxidants (Basel). 2022; 11(8).

PMID: 36009199 PMC: 9405273. DOI: 10.3390/antiox11081480.


Hydrogen Sulfide Regulates Irisin and Glucose Metabolism in Myotubes and Muscle of HFD-Fed Diabetic Mice.

Parsanathan R, Jain S Antioxidants (Basel). 2022; 11(7).

PMID: 35883859 PMC: 9311985. DOI: 10.3390/antiox11071369.


References
1.
Yang W, Yang G, Jia X, Wu L, Wang R . Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol. 2005; 569(Pt 2):519-31. PMC: 1464240. DOI: 10.1113/jphysiol.2005.097642. View

2.
Finck B, Kelly D . PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest. 2006; 116(3):615-22. PMC: 1386111. DOI: 10.1172/JCI27794. View

3.
Wang X, Jia X, Chang T, Desai K, Wu L . Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens. 2008; 26(4):765-72. DOI: 10.1097/HJH.0b013e3282f4a13c. View

4.
Manmontri B, Sariahmetoglu M, Donkor J, Bou Khalil M, Sundaram M, Yao Z . Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J Lipid Res. 2008; 49(5):1056-67. PMC: 2311443. DOI: 10.1194/jlr.M800013-JLR200. View

5.
Wang H, Peiris T, Mowery A, Le Lay J, Gao Y, Greenbaum L . CCAAT/enhancer binding protein-beta is a transcriptional regulator of peroxisome-proliferator-activated receptor-gamma coactivator-1alpha in the regenerating liver. Mol Endocrinol. 2008; 22(7):1596-605. PMC: 2453599. DOI: 10.1210/me.2007-0388. View